Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir + velpatasvir added to standard care for hospitalized adults with COVID-19
IRCT20130812014333N145Phase 3Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of sofosbuvir and velpatasvir in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Clinical status. Started Apr 2020; status: completed.
02
Drugs
sofosbuvirvelpatasvir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20130812014333N145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130812014333N145.